Cargando…

Correlation between the Warburg effect and progression of triple-negative breast cancer

Triple-negative breast cancer (TNBC) is ineligible for hormonal therapy and Her-2-targeted therapy due to the negative expression of the estrogen receptor, progesterone receptor, and human epidermal growth factor receptor-2. Although targeted therapy and immunotherapy have been shown to attenuate th...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Shaojun, Li, Yuxuan, Yuan, Meng, Song, Qing, Liu, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913723/
https://www.ncbi.nlm.nih.gov/pubmed/36776368
http://dx.doi.org/10.3389/fonc.2022.1060495
_version_ 1784885496168579072
author Liu, Shaojun
Li, Yuxuan
Yuan, Meng
Song, Qing
Liu, Min
author_facet Liu, Shaojun
Li, Yuxuan
Yuan, Meng
Song, Qing
Liu, Min
author_sort Liu, Shaojun
collection PubMed
description Triple-negative breast cancer (TNBC) is ineligible for hormonal therapy and Her-2-targeted therapy due to the negative expression of the estrogen receptor, progesterone receptor, and human epidermal growth factor receptor-2. Although targeted therapy and immunotherapy have been shown to attenuate the aggressiveness of TNBC partially, few patients have benefited from them. The conventional treatment for TNBC remains chemotherapy. Chemoresistance, however, impedes therapeutic progress over time, and chemotherapy toxicity increases the burden of cancer on patients. Therefore, introducing more advantageous TNBC treatment options is a necessity. Metabolic reprogramming centered on glucose metabolism is considered a hallmark of tumors. It is described as tumor cells tend to convert glucose to lactate even under normoxic conditions, a phenomenon known as the Warburg effect. Similar to Darwinian evolution, its emergence is attributed to the selective pressures formed by the hypoxic microenvironment of pre-malignant lesions. Of note, the Warburg effect does not disappear with changes in the microenvironment after the formation of malignant tumor phenotypes. Instead, it forms a constitutive expression mediated by mutations or epigenetic modifications, providing a robust selective survival advantage for primary and metastatic lesions. Expanding evidence has demonstrated that the Warburg effect mediates multiple invasive behaviors in TNBC, including proliferation, metastasis, recurrence, immune escape, and multidrug resistance. Moreover, the Warburg effect-targeted therapy has been testified to be feasible in inhibiting TNBC progression. However, not all TNBCs are sensitive to glycolysis inhibitors because TNBC cells flexibly switch their metabolic patterns to cope with different survival pressures, namely metabolic plasticity. Between the Warburg effect-targeted medicines and the actual curative effect, metabolic plasticity creates a divide that must be continuously researched and bridged.
format Online
Article
Text
id pubmed-9913723
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-99137232023-02-11 Correlation between the Warburg effect and progression of triple-negative breast cancer Liu, Shaojun Li, Yuxuan Yuan, Meng Song, Qing Liu, Min Front Oncol Oncology Triple-negative breast cancer (TNBC) is ineligible for hormonal therapy and Her-2-targeted therapy due to the negative expression of the estrogen receptor, progesterone receptor, and human epidermal growth factor receptor-2. Although targeted therapy and immunotherapy have been shown to attenuate the aggressiveness of TNBC partially, few patients have benefited from them. The conventional treatment for TNBC remains chemotherapy. Chemoresistance, however, impedes therapeutic progress over time, and chemotherapy toxicity increases the burden of cancer on patients. Therefore, introducing more advantageous TNBC treatment options is a necessity. Metabolic reprogramming centered on glucose metabolism is considered a hallmark of tumors. It is described as tumor cells tend to convert glucose to lactate even under normoxic conditions, a phenomenon known as the Warburg effect. Similar to Darwinian evolution, its emergence is attributed to the selective pressures formed by the hypoxic microenvironment of pre-malignant lesions. Of note, the Warburg effect does not disappear with changes in the microenvironment after the formation of malignant tumor phenotypes. Instead, it forms a constitutive expression mediated by mutations or epigenetic modifications, providing a robust selective survival advantage for primary and metastatic lesions. Expanding evidence has demonstrated that the Warburg effect mediates multiple invasive behaviors in TNBC, including proliferation, metastasis, recurrence, immune escape, and multidrug resistance. Moreover, the Warburg effect-targeted therapy has been testified to be feasible in inhibiting TNBC progression. However, not all TNBCs are sensitive to glycolysis inhibitors because TNBC cells flexibly switch their metabolic patterns to cope with different survival pressures, namely metabolic plasticity. Between the Warburg effect-targeted medicines and the actual curative effect, metabolic plasticity creates a divide that must be continuously researched and bridged. Frontiers Media S.A. 2023-01-27 /pmc/articles/PMC9913723/ /pubmed/36776368 http://dx.doi.org/10.3389/fonc.2022.1060495 Text en Copyright © 2023 Liu, Li, Yuan, Song and Liu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Liu, Shaojun
Li, Yuxuan
Yuan, Meng
Song, Qing
Liu, Min
Correlation between the Warburg effect and progression of triple-negative breast cancer
title Correlation between the Warburg effect and progression of triple-negative breast cancer
title_full Correlation between the Warburg effect and progression of triple-negative breast cancer
title_fullStr Correlation between the Warburg effect and progression of triple-negative breast cancer
title_full_unstemmed Correlation between the Warburg effect and progression of triple-negative breast cancer
title_short Correlation between the Warburg effect and progression of triple-negative breast cancer
title_sort correlation between the warburg effect and progression of triple-negative breast cancer
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913723/
https://www.ncbi.nlm.nih.gov/pubmed/36776368
http://dx.doi.org/10.3389/fonc.2022.1060495
work_keys_str_mv AT liushaojun correlationbetweenthewarburgeffectandprogressionoftriplenegativebreastcancer
AT liyuxuan correlationbetweenthewarburgeffectandprogressionoftriplenegativebreastcancer
AT yuanmeng correlationbetweenthewarburgeffectandprogressionoftriplenegativebreastcancer
AT songqing correlationbetweenthewarburgeffectandprogressionoftriplenegativebreastcancer
AT liumin correlationbetweenthewarburgeffectandprogressionoftriplenegativebreastcancer